7.3.1. clinical loco-regional lymph node metastases. evidence lacking regarding optimal management clinical node-positive disease. patients clinically n+ utuc offered downstaging first-line platinum-based chemotherapy. patients whose cancer responds stable disease, maintenance avelumab offered, especially cn2 disease . depending extent nodal disease (i.e., cn1/n2) surgical resection ln dissection discussed multidisciplinary team patient responding initial systemic therapy. patients whose cancer progress, second-line treatment offered, similar metastatic disease .